Sorrento Therapeutics logo

Sorrento Therapeutics

North America, California, United States, San Diego

Description

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

Investor Profile

Sorrento Therapeutics has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 40% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Private Equity, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Health Care, Biotechnology, Therapeutics.

Stage Focus

  • Series Unknown (20%)
  • Private Equity (20%)
  • Post Ipo Equity (20%)
  • Series B (20%)
  • Seed (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Therapeutics
  • Wellness
  • Life Science
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sorrento Therapeutics frequently co-invest with?

B
North America, Illinois, United States, Ohio
Co-Investments: 1
Green D Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1
NantWorks
North America, California, United States, Culver City
Co-Investments: 1
DL
Asia, Selangor, Malaysia, Ladang West Country
Co-Investments: 1
Celgene
North America, New Jersey, United States, Summit
Co-Investments: 1
Starr Insurance
North America, New York, United States, New York
Co-Investments: 1
United Therapeutics
North America, Maryland, United States, Silver Spring
Co-Investments: 1
Human Longevity
North America, California, United States, San Diego
Co-Investments: 1
Heritage Group
North America, Tennessee, United States, Nashville
Co-Investments: 1
Section 32
North America, California, United States, San Diego
Co-Investments: 1

Which angels does Sorrento Therapeutics often collaborate with?

BM
North America, California, United States, San Diego
Shared Deals: 1
TR
North America, California, United States, San Diego
Shared Deals: 1

What are some of recent deals done by Sorrento Therapeutics?

Aardvark Therapeutics

San Diego, California, United States

Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.

BiotechnologyHealth CareTherapeutics
Series BAug 5, 2021
Amount Raised: $29,000,000
Celularity

Florham Park, New Jersey, United States

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

BiotechnologyHealth CareTherapeuticsWellness
Post Ipo EquityJul 19, 2021
Amount Raised: $80,000,000
Celularity

Florham Park, New Jersey, United States

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

BiotechnologyHealth CareTherapeuticsWellness
Series UnknownFeb 15, 2018
Amount Raised: $250,000,000
Globavir

Los Altos, California, United States

A New Approach to Treating Global Infectious Diseases

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
SeedJan 31, 2015
Amount Raised: $4,000,000
NantiBodyFc

Cumming, Georgia, United States

Operates in the healthcare industry.

Health CareLife Science
Private EquityJan 1, 2015
Amount Raised: $10,000,000